Search research articles
Contact Us
Filters
Showing results (191-200 of 348) with videos related to
Page
of 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2005
Phase II trial of the novel retinoid, bexarotene, and gemcitabine plus carboplatin in advanced non-small-cell lung cancer
Martin J Edelman, Ruth Smith, Petr Hausner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2012
CYFRA 21-1 as a prognostic and predictive marker in advanced non-small-cell lung cancer in a prospective trial: CALGB 150304
Martin J Edelman, Lydia Hodgson, Paula Y Rosenblatt, et al.
Cancer Immunology, Immunotherapy : CII
|
March 7, 2008
Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells
Minu K Srivastava, Jacobus J Bosch, James A Thompson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 4, 2011
Multicenter phase II trial of Motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer
Martin J Edelman, Gregory Otterson, Joseph Leach, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 1, 2012
Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung
Mohan Suntharalingam, Rebecca Paulus, Martin J Edelman, et al.
Journal of Substance Use and Addiction Treatment
|
April 20, 2024
A trial of implementation facilitation to increase timely admission to methadone treatment
J Gryczynski, S G Mitchell, M Whitter, et al.
AIDS and Behavior
|
May 27, 2014
Sexual partner notification of HIV infection among a National United States-based sample of HIV-infected men
E J Edelman, K S Gordon, M Hogben, et al.
Urology
|
March 29, 2000
Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation
M J Edelman, F J Meyers, T R Miller, et al.
The Annals of Thoracic Surgery
|
October 7, 2004
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer
Joshua R Sonett, Mohan Suntharalingam, Martin J Edelman, et al.
Plos Biology
|
June 3, 2024
The COMBO window: A chronic cranial implant for multiscale circuit interrogation in mice
Bradley J Edelman, Dominique Siegenthaler, Paulina Wanken, et al.
Page
of 35
Search research articles
Search
Showing results (191-200 of 348) with videos related to
Sort By:
Page
of 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 20, 2005
Phase II trial of the novel retinoid, bexarotene, and gemcitabine plus carboplatin in advanced non-small-cell lung cancer
Martin J Edelman, Ruth Smith, Petr Hausner, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2012
CYFRA 21-1 as a prognostic and predictive marker in advanced non-small-cell lung cancer in a prospective trial: CALGB 150304
Martin J Edelman, Lydia Hodgson, Paula Y Rosenblatt, et al.
Cancer Immunology, Immunotherapy : CII
|
March 7, 2008
Lung cancer patients' CD4(+) T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells
Minu K Srivastava, Jacobus J Bosch, James A Thompson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 4, 2011
Multicenter phase II trial of Motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer
Martin J Edelman, Gregory Otterson, Joseph Leach, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 1, 2012
Radiation therapy oncology group protocol 02-29: a phase II trial of neoadjuvant therapy with concurrent chemotherapy and full-dose radiation therapy followed by surgical resection and consolidative therapy for locally advanced non-small cell carcinoma of the lung
Mohan Suntharalingam, Rebecca Paulus, Martin J Edelman, et al.
Journal of Substance Use and Addiction Treatment
|
April 20, 2024
A trial of implementation facilitation to increase timely admission to methadone treatment
J Gryczynski, S G Mitchell, M Whitter, et al.
AIDS and Behavior
|
May 27, 2014
Sexual partner notification of HIV infection among a National United States-based sample of HIV-infected men
E J Edelman, K S Gordon, M Hogben, et al.
Urology
|
March 29, 2000
Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation
M J Edelman, F J Meyers, T R Miller, et al.
The Annals of Thoracic Surgery
|
October 7, 2004
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer
Joshua R Sonett, Mohan Suntharalingam, Martin J Edelman, et al.
Plos Biology
|
June 3, 2024
The COMBO window: A chronic cranial implant for multiscale circuit interrogation in mice
Bradley J Edelman, Dominique Siegenthaler, Paulina Wanken, et al.
Page
of 35